To choose a biotech or pharma PR agency, match the agency to your development stage, check how it works with medical, legal and regulatory review, and ask who will handle scientists, investors and reporters. 5W's working range for a full-service healthcare program is $20,000 to $100,000 a month, depending on scope, and biotech and pharma programs fall inside it. No agency can guarantee coverage or an AI citation.
Last updated: October 27, 2026
Summary: Biotech and pharma communications change with the stage of the product: preclinical, clinical, approval and launch each have different audiences and different rules. This guide gives a stage-by-stage table, six questions for agencies, and the warning signs to watch for. It is general information, not legal advice, and legal and regulatory teams should review every claim before it is public.
In this guide:
- How the work changes by development stage
- Six questions to ask a biotech or pharma agency
- How AI answers treat pharma companies
- What a biotech or pharma agency costs
- Warning signs during selection
- Frequently asked questions
How Does Biotech and Pharma PR Change by Development Stage?
Biotech and pharma PR changes by development stage because the audience, the proof available and the rules on what can be said all shift as a product moves from lab to market. An agency should be able to describe the plan for your current stage and the next one.
| Stage | Main audiences | What the PR work focuses on |
|---|---|---|
| Preclinical | Investors, scientific peers, recruits | Founder and scientist positioning, funding news, conference presence |
| Clinical trials | Investors, trial sites, patient groups, trade press | Data readout planning, trial recruitment news, medical conference timing |
| Approval | Regulators, payers, clinicians, business press | Decision-date planning, holding statements, coordinated announcements |
| Launch and after | Clinicians, patients, payers, consumer press | Education, safety communications, reputation and search accuracy |
The same agency rarely fits every stage. A team strong in investor and trade media suits a clinical-stage company, and a team strong in consumer and patient communications suits a launch.
What Should You Ask a Biotech or Pharma PR Agency?
Six questions test whether a biotech or pharma agency can work inside your review process and reach the right audience. Ask every agency the same six.
- Which companies at my stage have you worked with, and which announcement did you plan for each?
- How do you work with our medical, legal and regulatory reviewers, and how many review cycles does a statement usually take?
- Who handles trade, business and investor media, and who handles patient and consumer media?
- How do you plan around data readouts, advisory committee dates and approval decisions?
- What is the crisis plan for a safety event, a regulatory letter or a failed trial?
- How will you monitor what ChatGPT, Gemini and Google AI Overviews say about our product?
The Food and Drug Administration's Office of Prescription Drug Promotion works to ensure that prescription drug promotion is truthful, balanced and accurately communicated, and its scope covers promotion made by or on behalf of a manufacturer. Ask who at the agency and at your company reviews every claim, and have regulatory counsel confirm which rules apply to your product.
How Do AI Answers Treat Pharma and Biotech Companies?
AI answers about pharma and biotech companies lean on a small set of sources, and company-owned pages are only part of them. 5W's pharma AI citation share analysis looks at which companies AI engines cite in 2026, and the healthcare AI visibility study compares two 2026 indices.
An agency can improve the accuracy of public information about a product by publishing clear pages, earning coverage and correcting errors at the source. A peer-reviewed study accepted to ACM KDD 2024, titled "GEO: Generative Engine Optimization," found that adding statistics, quotations from relevant sources and citations raised visibility in generative engine responses by up to 40%, with results varying by subject area.
For regulated products, accuracy matters more than reach. Ask the agency how it will confirm that every page and statement about a drug matches approved information, and who signs off before anything is published.
What Does a Biotech or Pharma PR Agency Cost?
A biotech or pharma PR agency costs $20,000 to $100,000 a month at 5W for a full-service healthcare program, depending on scope. A single announcement costs less than a year-round program with expert positioning, investor media and crisis readiness.
| Cost driver | What changes | Question to ask |
|---|---|---|
| Review cycles | Medical, legal and regulatory review adds time to each statement | Who reviews claims and how fast? |
| Announcement volume | Data, funding and approval news raises briefing work | Does the retainer cover each announcement? |
| Audiences covered | Investor, clinical, patient and consumer plans each need a team | Which audiences are in scope? |
| Crisis readiness | Planning and after-hours response add scope | Is crisis work in the retainer or billed per event? |
For a wider view of what healthcare programs cost, read the guide to healthcare PR campaign cost. The broader healthcare PR agency guide covers digital health, hospitals and devices, and explains the eight general selection questions.
Which Warning Signs Matter When Selecting a Biotech or Pharma Agency?
Five warning signs matter most when a biotech or pharma company selects an agency. Treat any of them as a reason to ask more questions.
- The proposal promises specific outlets, stock reactions, patient volume or AI recommendations
- The team cannot explain the difference between your development stage and the next one
- The agency has no written process for routing claims through medical, legal and regulatory review
- Senior people sell the work but will not name the daily account team
- Reporting counts clips and impressions only
What is an untitled letter?
An untitled letter is a communication from the FDA to a company about promotional material that the agency considers misleading or in violation of rules. Companies treat it as a signal to correct the material.
Frequently Asked Questions
How do I choose a biotech PR agency?
Match the agency to your development stage, check its claim review process, and compare 90-day plans from three agencies. Ask for a case study in your category.
How much does a pharma PR agency cost per month?
5W's working range for a full-service healthcare program is $20,000 to $100,000 a month, and pharma programs fall within it depending on scope.
Can an agency help with AI search accuracy for pharma?
An agency can improve accurate public pages and coverage that AI tools retrieve. Every statement about a drug should go through medical, legal and regulatory review first.
Is this guide legal advice?
No. This guide is general information, and regulatory counsel should confirm which FDA rules apply to a specific product.
Conclusion
A biotech or pharma company should pick an agency by stage and by review process before looking at logos or price. 5W works with healthcare companies on that selection. See the healthcare PR practice for how a program is built, the healthcare PR guide for the wider picture, and the GEO optimization practice page for how AI search work fits into a program.
